Product NewsQuanterix granted Breakthrough Device designation from U.S. FDA for blood-based pTau-181 assay for Alzheimer’s Disease
Editorial Article14 top research and technology stories showcased at the AACC Annual Scientific Meeting & Clinical Lab Expo 2021
Product NewsNew biomarker test accurately predicts progression to Alzheimer’s disease six years before diagnosis